Published in J Appl Physiol (1985) on October 01, 1991
Effects of PAF on excitatory neuro-effector transmission in dog airways. Br J Pharmacol (1992) 0.75
Failure of salmeterol to inhibit circulating white cell responses and bronchoconstriction induced by platelet activating factor. Thorax (1992) 0.75
Management of asthma with zafirlukast. Clinical experience and tolerability profile. Drugs (1996) 0.75
Resistance to -adrenoceptor stimulants (a possible explanation for the rise in ashtma deaths). Br J Pharmacol (1971) 6.11
Side effects of hypotensive agents evaluated by a self-administered questionnaire. Br Med J (1973) 5.65
How safe is general practitioner obstetrics? Lancet (1980) 4.51
Monitoring adverse reactions to drugs. Br Med J (1977) 4.41
Symptomatic adrenal insufficiency presenting with hypoglycaemia in children with asthma receiving high dose inhaled fluticasone propionate. BMJ (2002) 4.29
Prognosis of treated hypertension. Changes in life expectancy and causes of death between 1952 and 1967. Q J Med (1970) 3.71
A symptom questionnaire for hypertensive patients. J Chronic Dis (1974) 3.51
Isoprenaline resistance and the use of pressurised aerosols in asthma. Lancet (1968) 3.33
Comparison of cardiorespiratory effects of isoprenaline and salbutamol in patients with bronchial asthma. Br Med J (1970) 3.25
Clinical pharmacology and pharmacokinetics of clonidine. Clin Pharmacol Ther (1976) 3.13
Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis. Nature (2002) 2.71
Structure of slow-reacting substance of anaphylaxis from guinea-pig lung. Nature (1980) 2.69
Bradykinin-induced bronchoconstriction in humans. Mode of action. Am Rev Respir Dis (1987) 2.64
Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility. Lancet (1980) 2.63
Effect of propranolol in mild hypertension. Lancet (1966) 2.57
Measurement of Pseudomonas aeruginosa phenazine pigments in sputum and assessment of their contribution to sputum sol toxicity for respiratory epithelium. Infect Immun (1988) 2.56
Der p 1 facilitates transepithelial allergen delivery by disruption of tight junctions. J Clin Invest (1999) 2.53
Chemical structure of the morphogen differentiation inducing factor from Dictyostelium discoideum. Nature (1987) 2.49
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
Blood concentrations in man of fluorinated hydrocarbons after inhalation of pressurised aerosols. Lancet (1970) 2.48
Nasal acquisition of Staphylococcus aureus in a subdivided and mechanically ventilated ward: endemic prevalence of a single staphylococcal strain. J Hyg (Lond) (1970) 2.48
Prostacyclin is not a circulating hormone in man. Prostaglandins (1982) 2.46
European journals, societies, and meetings. Meetings. Br Med J (1973) 2.46
Incidence of a positive direct coombs test in patients on alpha-methyldopa. Lancet (1966) 2.44
Attenuation of hypotensive effect of propranolol and thiazide diuretics by indomethacin. Br Med J (1980) 2.36
Clinical medicine and research in France. Br Med J (1973) 2.32
Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects. Lancet (1991) 2.27
Computer-based hypertension clinic records: a co-operative study. Br Med J (1974) 2.24
Intravenously administered isoproterenol sulfate dose-response curves in man. Arch Intern Med (1972) 2.23
Positive direct Coombs tests and antinuclear factor in patients treated with methyldopa. Lancet (1967) 2.22
Circulating catecholamines in exercise and hyperventilation induced asthma. Thorax (1981) 2.22
Randomised controlled trial of computer-held medical records in hypertensive patients. Br Med J (1976) 2.15
Change in symptoms of hypertensive patients after referral to hospital clinic. Br Heart J (1976) 2.13
Capsaicin inhalation in man and the effects of sodium cromoglycate. Br J Pharmacol (1984) 2.12
FAB-mapping of recombinant-DNA protein products. Biochem Biophys Res Commun (1983) 2.08
The metabolic fate of DL(7-3H)isoprenaline in man and dog. Biochem J (1969) 2.06
The pharmacologic profile of fluoxetine. J Clin Psychiatry (1985) 2.04
Absorption and metabolism of nicotine from cigarettes. Br Med J (1975) 2.01
Clonidine withdrawal in hypertension. Changes in blood-pressure and plasma and urinary noradrenaline. Lancet (1977) 2.01
Capsaicin cough sensitivity decreases with successful treatment of chronic cough. Am J Respir Crit Care Med (1994) 1.99
I. Ophthalmoscopic and circulatory changes in focal retinal ischaemia. Br J Ophthalmol (1966) 1.99
Sensitivity of the cough reflex in patients with chronic cough. Eur Respir J (1992) 1.97
Pharmacokinetics of indoramin in man. Br J Clin Pharmacol (1976) 1.97
Syst-Eur. A multicentre trial on the treatment of isolated systolic hypertension in the elderly: objectives, protocol, and organization. Aging (Milano) (1991) 1.93
Aspiration pneumonia: dental and oral risk factors in an older veteran population. J Am Geriatr Soc (2001) 1.93
Clinical pharmacology of beta-receptor-blocking drugs. Clin Pharmacol Ther (1970) 1.92
Pharmacokinetics and concentration-effect relationships of intervenous and oral clonidine. Clin Pharmacol Ther (1977) 1.91
The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum. J Med Chem (1992) 1.89
Phagocytosis of apoptotic neutrophils does not induce macrophage release of thromboxane B2. J Leukoc Biol (1992) 1.85
Assessment of selective beta-adrenoceptor blockade in man. Br J Pharmacol (1973) 1.85
Smokeless tobacco and severe active periodontal disease, NHANES III. J Dent Res (2005) 1.83
Pathogenesis of hypertensive retinopathy. An experimental study in the monkey. Br J Ophthalmol (1975) 1.79
Rifampicin and vitamin D metabolism. Clin Pharmacol Ther (1980) 1.78
Clinical evaluation of indoramin, a new antihypertensive agent. Eur J Clin Pharmacol (1973) 1.78
Minoxidil in resistant hypertension. Lancet (1977) 1.77
Proinflammatory interactions of pyocyanin and 1-hydroxyphenazine with human neutrophils in vitro. J Infect Dis (1990) 1.77
The drug treatment of hypertension. Practitioner (1971) 1.75
Sensitivity of the human cough reflex: effect of inflammatory mediators prostaglandin E2, bradykinin, and histamine. Am Rev Respir Dis (1989) 1.75
Differential effects of fluticasone propionate on allergen-evoked bronchoconstriction and increased urinary leukotriene E4 excretion. Am Rev Respir Dis (1993) 1.74
Glucose intolerance in hypertensive patients treated with diuretics; a fourteen-year follow-up. Lancet (1982) 1.73
Vasopressin/serotonin interactions in the anterior hypothalamus control aggressive behavior in golden hamsters. J Neurosci (1997) 1.72
Experimental retinal branch vein occlusion. Am J Ophthalmol (1970) 1.72
2-Heptyl-4-hydroxyquinoline N-oxide, an antistaphylococcal agent produced by Pseudomonas aeruginosa. J Antimicrob Chemother (1992) 1.71
Role of nifedipine in treatment of hypertension. Br Med J (Clin Res Ed) (1983) 1.70
Self-reported measures for surveillance of periodontitis. J Dent Res (2013) 1.69
Local inhibition of converting enzyme and vascular responses to angiotensin and bradykinin in the human forearm. J Physiol (1989) 1.68
Determining dental checkup frequency. J Am Dent Assoc (1999) 1.67
Urinary leukotriene E4 after antigen challenge and in acute asthma and allergic rhinitis. Lancet (1989) 1.66
Prostaglandin D2 potentiates airway responsiveness to histamine and methacholine. Am Rev Respir Dis (1986) 1.65
Pharmacologic modification of serotonergic function: drugs for the study and treatment of psychiatric and other disorders. J Clin Psychiatry (1986) 1.65
Serum-insulin in essential hypertension and in peripheral vascular disease. Lancet (1966) 1.61
Bronchoconstrictor response to inhaled capsaicin in humans. J Appl Physiol (1985) (1985) 1.61
Editorial: Pharmacokinetics--master or servant? Eur J Clin Pharmacol (1973) 1.57
Clinical pharmacology of beta-reccer-atefoygolocarahp lnilcc clinical pharmacology of beta-receptor-blocking drugs. Clin Pharmacol Ther (1969) 1.56
Brain concentration of propranolol in relation to hypotensive effect in the rabbit with observations on brain propranolol levels in man. J Pharmacol Exp Ther (1975) 1.56
Pseudomonas aeruginosa pyocyanin and 1-hydroxyphenazine inhibit fungal growth. J Clin Pathol (1999) 1.54
Alveolar gas concentrations of fluorocarbons-11 and-12 in man after use of pressurized aerosols. Thorax (1974) 1.52
Periodontal disease and risk of fatal coronary heart and cerebrovascular diseases. J Cardiovasc Risk (1999) 1.51
Recognition and management of Kawasaki disease. CMAJ (2000) 1.51
Heparin kinetics in venous thrombosis and pulmonary embolism. Circulation (1976) 1.50
Long-term antihypertensive drug treatment and blood pressure control in three hospital hypertension clinics. Br Heart J (1980) 1.49
Slow-reacting substance of anaphylaxis: purification and characterisation. FEBS Lett (1978) 1.48
Measurement of 6-oxo-PGF1 alpha in human plasma using gas chromatography-mass spectrometry. Prostaglandins (1979) 1.48
Characterisation of Pseudomonas rhamnolipids. Biochim Biophys Acta (1990) 1.47
Increased pulmonary alpha-adrenergic and reduced beta-adrenergic receptors in experimental asthma. Nature (1980) 1.46
Effect of enalapril on the skin response to bradykinin in man. Br J Clin Pharmacol (1987) 1.46
Measurement of plasma histamine in asthma. Clin Allergy (1983) 1.46
Prevalence and trends in periodontitis in the USA: the [corrected] NHANES, 1988 to 2000. J Dent Res (2005) 1.44
Central hypotensive effect of propranolol in the rabbit. Br J Pharmacol (1973) 1.44
Surgical treatment of emphysema. Br Med J (1966) 1.44
Effect of nedocromil sodium on sulphur dioxide induced bronchoconstriction. Thorax (1987) 1.44
The importance of central adrenergic neurones in renal hypertension in rabbits. J Physiol (1974) 1.43
Purification and structural analysis of pyocyanin and 1-hydroxyphenazine. Eur J Biochem (1986) 1.43
Increased sensitivity and accuracy of phaeochromocytoma diagnosis achieved by use of plasma-adrenaline estimations and a pentolinium-suppression test. Lancet (1981) 1.42
Hypertension in the young. Q J Med (1967) 1.42